Vicarious Surgical (RBOTW) Short term Debt (2021 - 2022)
Vicarious Surgical (RBOTW) reported Short term Debt of $600000.0 for Q3 2022, little changed year-over-year from $600000.0 in Q3 2021, and little changed quarter-over-quarter from $600000.0 in Q2 2022.
Vicarious Surgical (RBOTW) Short term Debt (2021 - 2022) Analysis & Trends
Vicarious Surgical (RBOTW) has 2 years of Short term Debt data on file, last reported at $600000.0 in Q3 2022.
- Short term Debt for Q3 2022 came in at $600000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Sep 2022 was $600000.0 (changed 0.0% YoY), and the FY2021 annual result was $600000.0, changed N/A from the prior year.
- Short term Debt held at $600000.0 in Q3 2022 per RBOTW's latest filing, from $600000.0 in the prior quarter.
- Over five years, Short term Debt peaked at $600000.0 in Q3 2021 and troughed at $600000.0 in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Vicarious Surgical | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 600,000.00 |
| Jun 30, 2022 | 600,000.00 |
| Mar 31, 2022 | 600,000.00 |
| Dec 31, 2021 | 600,000.00 |
| Sep 30, 2021 | 600,000.00 |